Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2019; 15(7):1514-1522. doi:10.7150/ijbs.33658 This issue Cite

Research Paper

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418

Liang Wang, Liankang Sun, Yufeng Wang, Bowen Yao, Runkun Liu, Tianxiang Chen, Kangsheng Tu, Qingguang Liu, Zhikui Liu✉

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, 710061.

✉ Corresponding author: Zhikui Liu, Ph.D., MD, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, China. E-mail: liuzhikui.1234com; Phone: +086-029-85323905; Fax More

Citation:
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. Int J Biol Sci 2019; 15(7):1514-1522. doi:10.7150/ijbs.33658. https://www.ijbs.com/v15p1514.htm
Other styles

File import instruction

Abstract

Graphic abstract

Emerging evidence has indicated that abnormal microRNAs (miRNAs) participated in carcinogenesis and tumor progression in hepatocellular carcinoma (HCC). Better understanding the association between miRNAs and HCC may contribute to discover novel therapeutic approaches for diagnosis and treatments. In the current study, we have shown that miR-1204 level was elevated in HCC tissues and cell lines, which was associated with malignant clinical features, including large tumor size and advanced TNM stage. Furthermore, gain-or loss-of function assays demonstrated that miR-1204 promoted cell proliferation in vitro and tumor growth in vivo as well as inhibited apoptosis in vitro. Luciferase reporter gene assays confirmed that ZNF418 was a direct downstream target of miR-1204. Recuse assays showed that ZNF418 mediates the biological function of miR-1204 on HCC cells through regulating MAPK and c-Jun signaling. In conclusion, our results suggest that miR-1204 functions as an oncogene to promote proliferation and inhibit apoptosis through regulating MAPK and c-Jun signaling by targeting ZNF418, and potentially serves as a novel prognostic biomarker and therapeutic target for HCC.

Keywords: miR-1204, hepatocellular carcinoma, ZNF418, MAPK, c-Jun

Citation styles

APA
Wang, L., Sun, L., Wang, Y., Yao, B., Liu, R., Chen, T., Tu, K., Liu, Q., Liu, Z. (2019). miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. International Journal of Biological Sciences, 15(7), 1514-1522. https://doi.org/10.7150/ijbs.33658.

ACS
Wang, L.; Sun, L.; Wang, Y.; Yao, B.; Liu, R.; Chen, T.; Tu, K.; Liu, Q.; Liu, Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. Int. J. Biol. Sci. 2019, 15 (7), 1514-1522. DOI: 10.7150/ijbs.33658.

NLM
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. Int J Biol Sci 2019; 15(7):1514-1522. doi:10.7150/ijbs.33658. https://www.ijbs.com/v15p1514.htm

CSE
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. 2019. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418. Int J Biol Sci. 15(7):1514-1522.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use